Asked by: Lord Mann (Non-affiliated - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what was the monthly rate for child admissions for asthma into English hospitals in 2022.
Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)
A table is attached due to the size of the data involved. The information available on children admitted to hospital for asthma is shown in this table, with data for 2022 being provisional.
Data is not held by locality, but the number of admissions for children with asthma by hospital trust and by site, is provided in tab (i) within the table. The average number of monthly child admissions for asthma into English hospitals in 2022 is shown in tab (ii) within the table. Tab (iii) in the table shows the number of annual child hospital admissions for asthma in each of the past 20 years.
Asked by: Julian Sturdy (Conservative - York Outer)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to help ensure that children with suspected allergies receive a diagnosis.
Answered by Will Quince
To support healthcare professionals in ensuring that children with suspected allergies receive a diagnosis, the National Institute for Health and Care Excellence (NICE) has published a range of evidence-based best practice guidance for clinicians and commissioners. These include guidance on the diagnosis and treatment of drug and food allergy in under-19s [CG116]; the diagnosis and management of atopic eczema in the under-12s [CG57]; and diagnosing, monitoring, and managing asthma in adults, young people and children [NG80].
NICE guidelines represent best practice, and health professionals, including general practitioners, are expected to take them fully into account. It should be noted, however, that the guidelines are not mandatory and do not replace the judgement of clinicians in determining the most appropriate treatment for individual patients.
Asked by: Lord Watson of Wyre Forest (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government how many asthma reviews were conducted in England in each of the five most recent years for which figures are available.
Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)
The Quality Outcomes Framework (QOF) ensures all general practitioner practices establish and maintain a register of patients with an asthma diagnosis in accordance with National Institute for Health and Care Excellence guidance. Part of this guidance includes the provision of an annual Asthma review. The QOF annual review indicator was introduced in 2020/21 and contains Asthma review data from the past two years. In 2020/21 there were 1,132,926 and in 2021/22 there were 1,964,234. The 2022/23 data is to be published in September.
Asked by: Lord Watson of Wyre Forest (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what was the annual expenditure on asthma reviews in England for each of the five most recent years for which figures are available.
Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)
NHS England does not hold this information.
Asked by: Laurence Robertson (Conservative - Tewkesbury)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what recent estimate he has made of the number of people who have died as a result of asthma in (a) England and (b) Gloucestershire, in each of the last ten years for which figures are available.
Answered by Helen Whately - Minister of State (Department of Health and Social Care)
The Office for Health Improvement and Disparities publishes the Interactive Health Atlas of Lung conditions in England profile that includes asthma metrics and compares local areas within England. The profile includes the mortality rate from asthma.
The following table shows the number of deaths for the last 10 years.
Year | Gloucestershire CCG | England |
2011 | 8 | 982 |
2012 | 8 | 1,054 |
2013 | 8 | 1,037 |
2014 | 8 | 1,045 |
2015 | 12 | 1,221 |
2016 | 13 | 1,169 |
2017 | 9 | 1,236 |
2018 | 12 | 1,333 |
2019 | 13 | 1,202 |
2020 | 10 | 1,261 |
Asked by: Laurence Robertson (Conservative - Tewkesbury)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to help reduce the number of fatalities caused by asthma; and if he will make a statement.
Answered by Helen Whately - Minister of State (Department of Health and Social Care)
Action on chronic respiratory diseases is crucial as they are the third biggest contributor to Years of Life Lost in England. The Major Conditions Strategy will cover treatment and prevention for chronic respiratory diseases, including asthma. The Strategy will set out a strong and coherent policy agenda that sets out a shift to integrated, whole-person care, building on measures that we have already taken forward through the NHS Long Term Plan. Interventions set out in the Strategy will aim to alleviate pressure on the health system, as well as support the Government’s objective to increase healthy life expectancy and reduce ill-health related labour market inactivity.
Asked by: Laurence Robertson (Conservative - Tewkesbury)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the adequacy of guidance on asthma care; and if he will make a statement.
Answered by Helen Whately - Minister of State (Department of Health and Social Care)
Action on chronic respiratory diseases is crucial as they are the third biggest contributor to Years of Life Lost in England. The Major Conditions Strategy will cover treatment and prevention for chronic respiratory diseases, including asthma. The Strategy will set out a strong and coherent policy agenda that sets out a shift to integrated, whole-person care, building on measures that we have already taken forward through the NHS Long Term Plan. Interventions set out in the Strategy will aim to alleviate pressure on the health system, as well as support the Government’s objective to increase healthy life expectancy and reduce ill-health related labour market inactivity.
Asked by: Laurence Robertson (Conservative - Tewkesbury)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to improve care for people suffering from asthma; and if he will make a statement.
Answered by Helen Whately - Minister of State (Department of Health and Social Care)
Action on chronic respiratory diseases is crucial as they are the third biggest contributor to Years of Life Lost in England. The Major Conditions Strategy will cover treatment and prevention for chronic respiratory diseases, including asthma. The Strategy will set out a strong and coherent policy agenda that sets out a shift to integrated, whole-person care, building on measures that we have already taken forward through the NHS Long Term Plan. Interventions set out in the Strategy will aim to alleviate pressure on the health system, as well as support the Government’s objective to increase healthy life expectancy and reduce ill-health related labour market inactivity.
Asked by: Laurence Robertson (Conservative - Tewkesbury)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what recent estimate he has made of the number of people with asthma in (a) England and (b) Gloucestershire; and what assessment he has made of trends in the number of people with asthma in (i) England and (ii) Gloucestershire; and if he will make a statement.
Answered by Helen Whately - Minister of State (Department of Health and Social Care)
The Office for Health Improvement and Disparities publishes the Interactive Health Atlas of Lung conditions in England profile that includes asthma metrics and compares local areas within England. The profile includes the prevalence of asthma, as collected by the Quality Outcomes Framework, NHS Digital.
The main findings for NHS Gloucestershire CCG and England were in 2021/22 there were 46,646 people recorded with asthma in Gloucestershire, 7.3% of the population. In England there were 3,745,077 people recorded with asthma, 6.5% of the population. The percentage of people with asthma in Gloucestershire was higher than for England as a whole. The definition of the asthma registers changed in 2020/21 and earlier years data is not directly comparable. Longer trends cannot be calculated.
Asked by: Jim Shannon (Democratic Unionist Party - Strangford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether he has had discussions with the Secretary of State for Environment, Food and Rural Affairs on (a) F-gases in inhalers and (b) the switching of patients with (i) asthma and (ii) chronic obstructive pulmonary disease to a lower-carbon inhaler.
Answered by Helen Whately - Minister of State (Department of Health and Social Care)
There have been no specific discussions. The National Health Service remains committed to reducing the carbon impact of inhalers. As part of all inhaler prescriptions, structured medication reviews and asthma reviews, consideration should be given to moving patients to lower carbon options, where it is clinically appropriate to do so.
NHS England has worked with key partners, industry representatives, patient groups, and clinicians to develop a package of guidance and resources to support improved respiratory disease management and shared decision-making on inhaler choice. This includes both patient and clinician focused resources which includes but is not limited to, Asthma+Lung UK resources co-developed with NHS England on inhaler choice to support patients, NHS England case studies and videos to support systems and providers, and resources from the Royal College of General Practitioners and National Institute for Health and Care Excellence to support clinicians.